Advertisement
top banner image  

topleft corner image     top right corner image
 
ACCF/AHA Clinical Guidelines and Statements

CME logo image
bullet
bullet
bullet
bullet

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Img, 2010; 3:188-196, doi:10.1016/j.jcmg.2009.09.022
© 2010 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chahal, N. S.
Right arrow Articles by Senior, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chahal, N. S.
Right arrow Articles by Senior, R.

State-of-the-Art Paper

Clinical Applications of Left Ventricular Opacification

Navtej S. Chahal, MD, Roxy Senior, MD, DM*

Department of Cardiology, Northwick Park Hospital, Harrow, United Kingdom

* Reprint requests and correspondence: Prof. Roxy Senior, Department of Cardiovascular Medicine, Northwick Park Hospital, Harrow HA1 3UJ, United Kingdom (Email: roxysenior{at}cardiac-research.org).

The significant advances made in ultrasound microbubble technology now permits reliable, reproducible left ventricular opacification, and this review reiterates the evidence that has shown contrast echocardiography to be clinically effective, to reduce downstream costs and to spare patients further, potentially hazardous investigations. Despite the evidence and the advances, there remains ambivalence towards the administration of contrast agents in echocardiography laboratories throughout the world, particularly in the performance of rest studies. Therefore, this review also addresses some of the reasons for the suboptimal uptake of contrast agents and encourages physicians, sonographers, and accreditatory bodies to adopt a different approach towards the difficult-to-image patient.

Key Words: left ventricular • opacification • echocardiography

Abbreviations and Acronyms
  2DE = 2-dimensional echocardiography
  3DE = 3-dimensional echocardiography
  CAD = coronary artery disease
  CMR = cardiac magnetic resonance
  EAE = European Association of Echocardiography
  EF = ejection fraction
  FDA = Food and Drug Administration
  LV = left ventricular
  LVEF = left ventricular ejection fraction
  MI = mechanical index




This article has been cited by other articles:


Home page
Circ Cardiovasc ImagingHome page
D. Oxborough, R. Shave, D. Warburton, K. Williams, A. Oxborough, S. Charlesworth, H. Foulds, M. D. Hoffman, K. Birch, and K. George
Dilatation and Dysfunction of the Right Ventricle Immediately After Ultraendurance Exercise: Exploratory Insights From Conventional Two-Dimensional and Speckle Tracking Echocardiography
Circ Cardiovasc Imaging, May 1, 2011; 4(3): 253 - 263.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
T. H. Marwick and J. Narula
Contrast Echocardiography: Over-Achievement in Research, Under-Achievement in Practice?
J. Am. Coll. Cardiol. Img., February 1, 2010; 3(2): 224 - 225.
[Full Text] [PDF]



Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link